Table 1.
Laboratory findings.
DOI | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 |
---|---|---|---|---|---|---|---|---|---|
RBC ( × 106/μL) | 3.85 | 4.07 | 4.02 | 4.02 | 4.20 | 4.29 | 3.92 | 3.99 | 3.82 |
WBC ( × 103/μL) | 4.7 | 4.6 | 2.2 | 2.7 | 6.0 | 11.9 | 14.3 | 18 | 17.5 |
Platelet ( × 103/μL) | 203 | 217 | 258 | 298 | 367 | 409 | 255 | 438 | 458 |
Lymphocyte ( × 103/μL) | 0.54 | 0.77 | 0.96 | 0.73 | 1.30 | 1.95 | 2.32 | 1.71 | 2.67 |
Lymphocytes (%) | 11.6 | 16.8 | 42.9 | 27.2 | 21.6 | 16.4 | 16.2 | 9.5 | 15.2 |
Neutrophil ( × 103/μL) | 3.99 | 3.67 | 1.14 | 1.75 | 3.92 | 8.49 | 9.97 | 14.47 | 12.34 |
Neutrophil (%) | 85.9 | 80.0 | 50.9 | 65.3 | 65.0 | 71.6 | 69.6 | 80.3 | 70.5 |
Creatine kinase (U/L) | 90 | - | - | - | - | - | - | - | - |
BUN (mmol/L) | 10 | 9 | 8 | 7 | 12 | 21 | 21 | 15 | 17 |
Serum creatinine (mg/dL) | 0.65 | 0.69 | 0.67 | 0.64 | 0.74 | 0.76 | 0.64 | 0.62 | 0.66 |
eGFR | 125 | 116 | 121 | 127 | 107 | 104 | 127 | 132 | 123 |
hs-CRP (mg/dL) | 14.09 | 8.92 | 2.20 | 1.36 | 0.54 | 0.34 | 0.33 | 0.26 | |
D-dimer (mg/L FEU) | 1.55 | - | 2.33 | 3.310 | 5.470 | 3.480 | 2.360 | 2.580 | 2.030 |
LDH (U/L) | - | - | 562 | - | 445 | 356 | 320 | 354 | 259 |
Ferritin (ng/ml) | - | 547.1 | 654.8 | - | 465.1 | 267.6 | 189.9 | 208.0 | 184.4 |
IL-6 (pg/ml) | - | 27.8 | - | - | - | - | 69.2 | 10.1 | 8.6 |
VEGF, plasma (pg/ml) | - | 53 | - | - | - | - | 143 | 104 | 245 |
TNF-α (pg/ml) | - | 1.4 | - | - | - | 0.8 | 1.2 | 0.8 | 1.2 |
vWF Ag (IU/dL) | - | 184 | - | - | - | 159 | 167 | 192 | 191 |
DOI, Day of Illness; hs-CRP, high sensitivity C reactive protein; BUN, Blood Urea Nitrogen; eGFR, Estimated Glomerular Filtration Rate; IL-6, Interleukin-6; LDH, Lactate dehydrogenase; VEGF, Vascular Endothelial Growth Factor; TNF-α, Tumor Necrosis Factor-α; vWF Ag, von Willebrand Factor antigen.